Konica Minolta (4902) AI Stock Analysis

• Market Cap: $253.52B
• Dividend Yield: 0.96%
• Average Volume (3M): 3.04M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.02
• Revenue Growth: -7.37%
• EPS Growth: -653.50%
• Country: JP
• Employees: 38,263
• Sector: Industrials
• Sector Strength: 79
• Industry: Business Equipment & Supplies
• EPS (TTM): 14.74
• Shares Outstanding: 502,664,340
• 10 Day Avg. Volume: 2,230,930
• 30 Day Avg. Volume: 3,035,906
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 2.32
• Enterprise Value/Revenue: 0.52
• Enterprise Value/Gross Profit: 1.23
• Enterprise Value/Ebitda: 13.98
• 1Y Price Target: $540.70
• Price Target Upside: 5.79% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 4

• Rating: 52 Neutral
• Price Target: ¥485.00 ▼(-5.11% Downside)

Konica Minolta's overall stock score reflects significant financial performance concerns, with negative profitability metrics being a primary risk. While technical indicators provide a slight positive momentum, the valuation remains unattractive due to a negative P/E ratio. Addressing profitability and operational inefficiencies is crucial for long-term stability.

Konica Minolta Business Overview & Revenue Model

Company Description

Konica Minolta, Inc. engages in digital workplace, professional print, healthcare, and industrial businesses in Japan, the United States, Europe, China, other Asian countries, and internationally. The company develops, manufactures, and sells multi-functional peripherals, digital printing systems, and related consumables, as well as IT and printing solutions and services. It also provides healthcare systems, such as digital X-ray diagnostic imaging, diagnostic ultrasound systems, and other systems, as well as digitalization, networking, solutions, and services in the medical field; genetic diagnostic and drug discovery support services. In addition, the company offers measuring instruments; functional film displays; organic light emitting diode lighting products; industrial inkjet printheads; lenses for industrial and professional use; and imaging-IoT and visual solutions. Konica Minolta, Inc. was founded in 1873 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Konica Minolta generates revenue through multiple streams, primarily from the sale of its products and services across its business segments. The Business Technologies segment, which includes office equipment like multifunction printers and IT services, is a significant contributor to its earnings. The company also earns from its Healthcare segment by providing diagnostic imaging solutions, such as X-ray and ultrasound systems, to medical institutions. Additionally, Konica Minolta's Industrial Business segment includes the sale of optical devices and measuring instruments. The company leverages strategic partnerships and acquisitions to expand its market presence and enhance its technological capabilities, which further contribute to its revenue growth.

Konica Minolta Financial Statement Overview

Summary

Konica Minolta faces profitability challenges with declining revenue and high leverage. Despite some cash flow resilience, operational inefficiencies and negative profit margins undermine financial stability.

Income Statement

Konica Minolta's income statement reveals challenges with profitability. The gross profit margin has been declining, and the company reported a negative net profit margin in the latest fiscal year, indicating losses. Although revenue growth was seen in earlier years, recent periods have shown a decline. The negative EBIT and EBITDA margins highlight operational inefficiencies and financial distress.

Balance Sheet

The balance sheet shows a moderate financial position. The debt-to-equity ratio indicates a high level of leverage, suggesting potential risk if earnings do not improve. However, the equity ratio is above average, which provides some stability. Return on equity has been negative, aligning with the company's recent losses.

Cash Flow

The cash flow statement presents mixed signals. While operating cash flows remain positive, free cash flow has been inconsistent, with recent improvements. The operating cash flow to net income ratio is high due to negative net income, complicating profitability assessment. The ability to generate cash flow is crucial for financial stability.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	1.13T	1.16T	1.13T	911.43B	863.38B
Gross Profit	479.42B	504.68B	485.94B	392.74B	374.65B
EBITDA	-60.74B	102.63B	105.59B	60.35B	66.32B
Net Income	-47.85B	4.52B	-103.15B	-26.12B	-15.21B
Balance Sheet
Total Assets	1.22T	1.39T	1.41T	1.34T	1.30T
Cash, Cash Equivalents and Short-Term Investments	89.90B	127.13B	183.06B	118.64B	127.03B
Total Debt	438.17B	522.58B	568.29B	448.65B	410.70B
Total Liabilities	743.56B	834.67B	913.90B	776.62B	749.05B
Stockholders Equity	463.15B	539.82B	487.42B	549.81B	539.89B
Cash Flow
Free Cash Flow	25.30B	38.21B	-27.46B	-23.61B	37.86B
Operating Cash Flow	51.09B	83.34B	13.32B	37.44B	78.06B
Investing Cash Flow	24.65B	-44.53B	-37.50B	-51.00B	-34.33B
Financing Cash Flow	-110.90B	-96.85B	84.32B	2.13B	-13.09B

Konica Minolta Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 511.10
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4902, the sentiment is Positive. The current price of 511.1 is above the 20-day moving average (MA) of 508.53, above the 50-day MA of 481.78, and below the 200-day MA of 535.10, indicating a neutral trend. The MACD of 9.75 indicates Positive momentum. The RSI at 56.25 is Neutral, neither overbought nor oversold. The STOCH value of 38.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4902.

Konica Minolta Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	64 Neutral	$10.96B	16.35	8.89%	1.96%	2.68%	-15.17%
4902	52 Neutral	$253.52B	―	-16.55%	0.96%	-7.37%	-653.50%
RICO	―	¥756.30B	15.94	4.52%	2.94%	―	―
BRTHF	―	$4.39B	13.93	7.32%	3.77%	―	―
FUJIF	―	$29.27B	17.14	7.61%	1.85%	―	―
CNJ	―	€3.63B	15.39	9.53%	―	―	―

Konica Minolta Corporate Events

Konica Minolta’s Strategic Shift Boosts Profitability Despite Revenue Decline

Konica Minolta reported a decline in revenue by 8.2% for the three months ending June 30, 2025, compared to the same period last year, yet achieved a significant turnaround in profitability with a 411% increase in business contribution profit and a notable operating profit. This financial performance reflects the company’s strategic shift, including the discontinuation of its Precision Medicine Business, which has streamlined operations and improved profitability, signaling a positive outlook for stakeholders.

The most recent analyst rating on (JP:4902) stock is a Hold with a Yen500.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.

Konica Minolta Finalizes Subsidiary Share Transfer

Konica Minolta has completed the transfer of shares of its subsidiary, Konica Minolta Marketing Services Holding Company Limited, to adm Group LIMITED. This change, effective June 30, 2025, results in the exclusion of the subsidiary from Konica Minolta’s consolidated financial statements, with minimal impact expected on the company’s financial results for the fiscal year ending March 31, 2026.

The most recent analyst rating on (JP:4902) stock is a Hold with a Yen500.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.

Konica Minolta Reports Decline in Profitability for Fiscal Year 2025

Konica Minolta reported its consolidated financial results for the fiscal year ending March 31, 2025, showing a slight increase in revenue but a significant decline in operating profit and overall profitability compared to the previous year. The company has classified its Precision Medicine Business as a discontinued operation, impacting its financial metrics. The results indicate challenges in maintaining profitability, with a notable decrease in total assets and equity, and a negative cash flow from financing activities, which may affect stakeholders’ confidence.

The most recent analyst rating on (JP:4902) stock is a Buy with a Yen750.00 price target. To see the full list of analyst forecasts on Konica Minolta stock, see the JP:4902 Stock Forecast page.